Video - Protease inhibitors
00:00 / 00:00
More Videos
04:07
Mechanisms of antibiotic resistance
10:46
Antimetabolites: Sulfonamides and trimethoprim
14:06
Antituberculosis medications
15:07
Cell wall synthesis inhibitors: Cephalosporins
13:49
Cell wall synthesis inhibitors: Penicillins
07:11
DNA synthesis inhibitors: Fluoroquinolones
05:24
DNA synthesis inhibitors: Metronidazole
15:09
Miscellaneous cell wall synthesis inhibitors
15:19
Miscellaneous protein synthesis inhibitors
11:25
Protein synthesis inhibitors: Aminoglycosides
10:45
Protein synthesis inhibitors: Tetracyclines
Video Summary
Protease inhibitors (PIs) are a class of antiviral drugs that are widely used to manage HIV/AIDS. Protease inhibitors prevent viral replication by selectively binding the enzyme HIV-1 protease, and prevent the formation of new viruses and further infection of the host's cells. Common medications in this class include atazanavir, darunavir, indinavir, lopinavir, tipranavir, and ritonavir. Common side effects of protease inhibitors include gastrointestinal problems such as diarrhea, nausea, and vomiting; and metabolic disorders such as hyperglycemia, insulin resistance, and hyperlipidemia.